Andrew Obenshain, President and CEO at bluebird bio, Inc. (BLUE), sold 971 shares at $0.42 ($408) on 2024-12-10, disclosed to the SEC on 2024-12-12.
Open-market sale of $408 BLUE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLUE | SELL | 2025-01-08 | $1K | — | Filing → |
| BLUE | SELL | 2024-10-02 | $18K | — | Filing → |
| BLUE | SELL | 2024-03-05 | $9K | — | Filing → |